
Metformin (500mg) + Pioglitazone (15mg) + Glimepiride (1mg)
Active composition
+2 more active ingredients
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ), enhancing insulin sensitivity and glucose metabolism.
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Endoformin PG 1mg/500mg/15mg Tablet SR is a triple combination medication containing Glimepiride, Metformin, and Pioglitazone that helps support effective blood glucose management. Glimepiride stimulates the pancreas to release insulin, helping lower blood sugar levels. Metformin works by reducing glucose production in the liver and improving insulin sensitivity. Pioglitazone helps improve the body’s response to insulin and supports better glucose utilization. The sustained release formulation allows gradual release of the medicine, providing longer lasting blood sugar control throughout the day. Maintaining stable blood glucose levels is important for preventing complications associated with diabetes and supporting overall metabolic health. The medicine is usually taken according to the dosage prescribed by a healthcare professional who monitors treatment progress. When combined with balanced diet and regular physical activity, Endoformin PG Tablet SR helps support effective diabetes management and metabolic balance.
How to use Endoformin PG Tablet SR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Endoformin PG 1mg/500mg/15mg Tablet SR is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Endoformin PG 1mg/500mg/15mg Tablet SR.
High Risk
Endoformin PG 1mg/500mg/15mg Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Endoformin PG 1mg/500mg/15mg Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Endoformin PG 1mg/500mg/15mg Tablet SR may be needed. Please consult your doctor. Use of Endoformin PG 1mg/500mg/15mg Tablet SR is not recommended in patients with severe liver disease.
Regular Checkup
Endoformin PG 1mg/500mg/15mg Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Endoformin PG 1mg/500mg/15mg Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Endoformin PG 1mg/500mg/15mg Tablet SR may be needed. Please consult your doctor. Use of Endoformin PG 1mg/500mg/15mg Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Endoformin PG 1mg/500mg/15mg Tablet SR

Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ), enhancing insulin sensitivity and glucose metabolism.
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Endoformin PG 1mg/500mg/15mg Tablet SR is a triple combination medication containing Glimepiride, Metformin, and Pioglitazone that helps support effective blood glucose management. Glimepiride stimulates the pancreas to release insulin, helping lower blood sugar levels. Metformin works by reducing glucose production in the liver and improving insulin sensitivity. Pioglitazone helps improve the body’s response to insulin and supports better glucose utilization. The sustained release formulation allows gradual release of the medicine, providing longer lasting blood sugar control throughout the day. Maintaining stable blood glucose levels is important for preventing complications associated with diabetes and supporting overall metabolic health. The medicine is usually taken according to the dosage prescribed by a healthcare professional who monitors treatment progress. When combined with balanced diet and regular physical activity, Endoformin PG Tablet SR helps support effective diabetes management and metabolic balance.
How to use Endoformin PG Tablet SR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Endoformin PG 1mg/500mg/15mg Tablet SR is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Endoformin PG 1mg/500mg/15mg Tablet SR.
High Risk
Endoformin PG 1mg/500mg/15mg Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Endoformin PG 1mg/500mg/15mg Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Endoformin PG 1mg/500mg/15mg Tablet SR may be needed. Please consult your doctor. Use of Endoformin PG 1mg/500mg/15mg Tablet SR is not recommended in patients with severe liver disease.
Regular Checkup
Endoformin PG 1mg/500mg/15mg Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Endoformin PG 1mg/500mg/15mg Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Endoformin PG 1mg/500mg/15mg Tablet SR may be needed. Please consult your doctor. Use of Endoformin PG 1mg/500mg/15mg Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Endoformin PG 1mg/500mg/15mg Tablet SR













